Carole Ho - Jun 4, 2025 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Director
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Jun 4, 2025
Transactions value $
$0
Form type
4
Date filed
6/6/2025, 04:05 PM
Previous filing
Jan 8, 2025
Next filing
Jul 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ho Carole Director C/O BEAM THERAPEUTICS INC.,, 238 MAIN STREET, CAMBRIDGE By: /s/ Christine Bellon, Attorney-in-fact 2025-06-06 0001724605

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +33.7K $0.00 33.7K Jun 4, 2025 Common Stock 33.7K $17.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.